Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AD-113 by Shionogi-Apnimed Sleep Science for Obstructive Sleep Apnea: Likelihood of Approval
AD-113 is under clinical development by Shionogi-Apnimed Sleep Science and currently in Phase II for Obstructive Sleep Apnea. According to...